In the latest report, CGTN reported that BGI Genomics launched its AI-powered "133111i Multi-omics Precision Health Management System," integrating big data and multi-omics analytics to advance disease prevention and public health. International experts highlight its potential to address global health challenges through scalable, data-driven solutions.

Now we turn to South China's Shenzhen city, where a major Chinese biotech company has just introduced a new health management system that uses AI and big data to help prevent diseases. The system aims to make precision medicine more accessible to the public. Our reporter Xu Hua explores how it works.

China's leading life science company, BGI Group, released its "Multi-omics precision health management system" on September 9 – a new tool designed to use AI and big data to improve public health.

ZHU SHIDA Vice President, BGI Genomics "The 133111i system digitizes health samples, including one baseline test (genomics, physiology, questionnaires), three types of test samples (multi-omics blood/urine/stool testing), three imaging sets (ultrasound/CT/MRI fusion), one scope (endoscopic/microscopic exam), one physiology (wearable monitoring), and one brain science (brain activity and omics analysis). It analyses millions of datasets to create a 'Life Index' for precise disease prevention and health management."

XU HUA Shenzhen "Behind the newly-released system is the company's GigaLab, which processes substantial volumes of medical data with both speed and precision. Here in Shenzhen, let's see how the lab supports the analysis of complex health information."

WANG YANQI Vice President of BGI Genomics, General Director of GigaLab "Our lab's core strengths lie in BGI Genomics' vast multi-omics database with cohort study and algorithms, and 20 years of hands-on experience optimizing tools for multi-omics precision health management, enabling simpler adoption of data-driven health solutions."

This system isn't just a lab idea, it's already being used in public health projects in cities like Wuhan and Harbin.

CAO YANG Vice President, Harbin Sixth Hospital "Harbin authorities have launched a three-year free screening program starting in 2024, covering 2.4 million residents for digestive tumours and metabolic conditions."

The global medical community is taking note of such innovations. International experts see potential for this system to address broader health challenges worldwide.

EVGENY KLIMUK Deputy Head of Biotechnology Campus, Russia "Most of the countries they're trying to develop something like this. And if China can help these countries, they will skip a lot of steps that will help them to gain their goals faster."

VADIM STEPANOV Director, Tomsk National Medical Research Center, Russia "I see the potential of this new BGI system to be a real part of health care not only in China, but also to society, to people, and to the average citizen."

Health experts say China's tech-driven model could offer valuable insights for other nations dealing with similar public health issues.

Xu Hua, CGTN, Shenzhen, Guangdong Province.

Original Link:  https://news.cgtn.com/news/2025-09-09/VHJhbnNjcmlwdDg2MzMx/index.html